BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

36 related articles for article (PubMed ID: 17383046)

  • 1. Twenty Years of Ferroportin Disease: A Review or An Update of Published Clinical, Biochemical, Molecular, and Functional Features.
    Vlasveld LT; Janssen R; Bardou-Jacquet E; Venselaar H; Hamdi-Roze H; Drakesmith H; Swinkels DW
    Pharmaceuticals (Basel); 2019 Sep; 12(3):. PubMed ID: 31505869
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Ferroportin deficiency in erythroid cells causes serum iron deficiency and promotes hemolysis due to oxidative stress.
    Zhang DL; Ghosh MC; Ollivierre H; Li Y; Rouault TA
    Blood; 2018 Nov; 132(19):2078-2087. PubMed ID: 30213870
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Structure-function analysis of ferroportin defines the binding site and an alternative mechanism of action of hepcidin.
    Aschemeyer S; Qiao B; Stefanova D; Valore EV; Sek AC; Ruwe TA; Vieth KR; Jung G; Casu C; Rivella S; Jormakka M; Mackenzie B; Ganz T; Nemeth E
    Blood; 2018 Feb; 131(8):899-910. PubMed ID: 29237594
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Ferroportin disease: pathogenesis, diagnosis and treatment.
    Pietrangelo A
    Haematologica; 2017 Dec; 102(12):1972-1984. PubMed ID: 29101207
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Hamp1 but not Hamp2 regulates ferroportin in fish with two functionally distinct hepcidin types.
    Neves JV; Ramos MF; Moreira AC; Silva T; Gomes MS; Rodrigues PNS
    Sci Rep; 2017 Nov; 7(1):14793. PubMed ID: 29093559
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Ferroportin disease: a systematic meta-analysis of clinical and molecular findings.
    Mayr R; Janecke AR; Schranz M; Griffiths WJ; Vogel W; Pietrangelo A; Zoller H
    J Hepatol; 2010 Nov; 53(5):941-9. PubMed ID: 20691492
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Genetic mechanisms and modifying factors in hereditary hemochromatosis.
    Weiss G
    Nat Rev Gastroenterol Hepatol; 2010 Jan; 7(1):50-8. PubMed ID: 19918260
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The hepcidin-binding site on ferroportin is evolutionarily conserved.
    De Domenico I; Nemeth E; Nelson JM; Phillips JD; Ajioka RS; Kay MS; Kushner JP; Ganz T; Ward DM; Kaplan J
    Cell Metab; 2008 Aug; 8(2):146-56. PubMed ID: 18680715
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Iron overload due to mutations in ferroportin.
    De Domenico I; Ward DM; Musci G; Kaplan J
    Haematologica; 2006 Jan; 91(1):92-5. PubMed ID: 16434376
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Hepcidin--the discovery of a small protein with a pivotal role in iron homeostasis].
    Sela BA
    Harefuah; 2008 Mar; 147(3):261-6, 276. PubMed ID: 18488871
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A novel mutation in ferroportin implicated in iron overload.
    Wallace DF; Dixon JL; Ramm GA; Anderson GJ; Powell LW; Subramaniam VN
    J Hepatol; 2007 May; 46(5):921-6. PubMed ID: 17383046
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Identification of mutations in SLC40A1 that affect ferroportin function and phenotype of human ferroportin iron overload.
    Mayr R; Griffiths WJ; Hermann M; McFarlane I; Halsall DJ; Finkenstedt A; Douds A; Davies SE; Janecke AR; Vogel W; Cox TM; Zoller H
    Gastroenterology; 2011 Jun; 140(7):2056-63, 2063.e1. PubMed ID: 21396368
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Immunolocalization and regulation of iron handling proteins ferritin and ferroportin in the retina.
    Hahn P; Dentchev T; Qian Y; Rouault T; Harris ZL; Dunaief JL
    Mol Vis; 2004 Aug; 10():598-607. PubMed ID: 15354085
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Primary iron overload with inappropriate hepcidin expression in V162del ferroportin disease.
    Zoller H; McFarlane I; Theurl I; Stadlmann S; Nemeth E; Oxley D; Ganz T; Halsall DJ; Cox TM; Vogel W
    Hepatology; 2005 Aug; 42(2):466-72. PubMed ID: 15986403
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A novel missense mutation in SLC40A1 results in resistance to hepcidin and confirms the existence of two ferroportin-associated iron overload diseases.
    Létocart E; Le Gac G; Majore S; Ka C; Radio FC; Gourlaouen I; De Bernardo C; Férec C; Grammatico P
    Br J Haematol; 2009 Nov; 147(3):379-85. PubMed ID: 19709084
    [TBL] [Abstract][Full Text] [Related]  

  • 16.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 17.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 18.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 19.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 2.